GENEMATRIX INC. Logo

GENEMATRIX INC.

Develops multiplex PCR diagnostic products for infectious diseases.

109820 | KO

Overview

Corporate Details

ISIN(s):
KR7109820001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 삼평동 코리아바이오파크 8층,7층, 성남시

Description

GENEMATRIX INC. is a biotechnology company that develops molecular diagnostic products and promotes new drug development. The company specializes in multiplex real-time PCR technology, which enables the simultaneous detection of multiple pathogens in a single test. Its core product line, NeoPlex™, offers a range of diagnostic assays for infectious diseases, including comprehensive panels for respiratory viruses and bacteria, human papillomavirus (HPV), and tuberculosis. GENEMATRIX focuses on creating innovative platform technologies to advance diagnostics and is also expanding into AI-powered solutions for precision medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-03-22 00:00
사업보고서 (2020.12)
Korean 845.4 KB
2021-03-15 00:00
주주총회소집공고
Korean 95.6 KB
2021-03-15 00:00
주주총회집중일개최사유신고
Korean 5.4 KB
2021-03-11 00:00
주주총회소집결의
Korean 10.0 KB
2021-02-15 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.5 KB
2020-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2020-11-16 00:00
분기보고서 (2020.09)
Korean 601.2 KB
2020-10-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.6 KB
2020-10-08 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.4 KB
2020-10-08 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.4 KB
2020-10-07 00:00
주식등의대량보유상황보고서(일반)
Korean 93.4 KB
2020-10-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.6 KB
2020-10-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.5 KB
2020-10-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.6 KB
2020-09-29 00:00
[기재정정]주식등의대량보유상황보고서(약식)
Korean 63.7 KB

Automate Your Workflow. Get a real-time feed of all GENEMATRIX INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEMATRIX INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEMATRIX INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.